|
ZNF81 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.23579999999901E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.382600E-04 |
| Normal-vs-Stage2 |
8.023200E-03 |
| Normal-vs-Stage3 |
2.17959999999628E-05 |
| Normal-vs-Stage4 |
4.27090000032493E-08 |
| Stage1-vs-Stage2 |
8.100000E-01 |
| Stage1-vs-Stage3 |
2.406000E-01 |
| Stage1-vs-Stage4 |
5.563500E-03 |
| Stage2-vs-Stage3 |
5.602200E-01 |
| Stage2-vs-Stage4 |
1.041400E-01 |
| Stage3-vs-Stage4 |
1.629570E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.42750000001291E-06 |
| Normal-vs-AfricanAmerican |
2.016000E-04 |
| Normal-vs-Asian |
8.202000E-01 |
| Caucasian-vs-AfricanAmerican |
1.932990E-01 |
| Caucasian-vs-Asian |
1.077800E-01 |
| AfricanAmerican-vs-Asian |
8.453900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.37629999996669E-06 |
| Normal-vs-Female |
7.68710000000894E-05 |
| Male-vs-Female |
5.191400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.52789999999992E-05 |
| Normal-vs-Age(41-60Yrs) |
4.839300E-04 |
| Normal-vs-Age(61-80Yrs) |
4.81629999993238E-07 |
| Normal-vs-Age(81-100Yrs) |
4.939900E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.505900E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.826400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.107400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.012760E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.068800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.864600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.507000E-01 |
| Normal-vs-Grade 2 |
3.813300E-04 |
| Normal-vs-Grade 3 |
1.93826000000064E-05 |
| Normal-vs-Grade 4 |
1.23260002204972E-09 |
| Grade 1-vs-Grade 2 |
4.756000E-01 |
| Grade 1-vs-Grade 3 |
3.574000E-01 |
| Grade 1-vs-Grade 4 |
1.168590E-01 |
| Grade 2-vs-Grade 3 |
3.119000E-01 |
| Grade 2-vs-Grade 4 |
3.165300E-04 |
| Grade 3-vs-Grade 4 |
6.019600E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.317300E-03 |
| Normal-vs-ccB subtype |
5.168000E-04 |
| ccA subtype-vs-ccB subtype |
4.116800E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.352000E-04 |
| Normal-vs-N1 |
1.400270E-03 |
| N0-vs-N1 |
2.086000E-01 |
|
|
